HDAC6 can control tumor growth and halt metastasis in triple-negative breast cancer – Medical Xpress

Genetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer in vivo, according to a new study published in the top-tier journal Cancer Research by investigators at the George Washington University (GW) Cancer Center.
Immunotherapythe use of drugs to stimulate one’s own immune system to recognize and destroy cancer cellshas been wildly successful in melanoma and other cancers. However, it has been less effective in breast cancer.
“There is an ur…

Click here to view the original article.